Quectel Expands Small Cell Antennas Portfolio With Five New Products
3.3.2026 08:00:00 CET | Business Wire | Press release
Quectel Wireless Solutions, a global end-to-end IoT solutions provider, has introduced five new small cell antennas to add further functionality and provide greater flexibility and choice for customers designing and implementing small cell deployments. The new antennas bring an additional range of form factors, mounting options and performance characteristics to the Quectel antenna range.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302915004/en/
Quectel expands small cell antennas portfolio with five new products
“Whether you’re looking for an antenna to support critical wireless communications, dense stadium usage scenarios or ultimate capacity, these five new Quectel antennas have been designed to meet your needs,” says David Wei, Antenna Product Head, Quectel Wireless Solutions. “The new antennas augment our already comprehensive range of antennas, bring further choice and add capabilities for developers and engineers.”
The YECJ095JPAM is a 5G ceiling mount omnidirectional antenna that operates in the 380-6000MHz frequency band. With a diameter of 300mm and height of 139mm, the RoHS compliant antenna supports 5G, LTE, 3G, 2G and Wi-Fi. The antenna features consistent vertical polarization and a 360° omnidirectional horizontal radiation pattern to provide reliable wide-area coverage in indoor environments. Built for easy ceiling mounting, the YECJ095JPAM offers future-proof, reliable and compliant connectivity for demanding indoor wireless infrastructure deployments.
The YEMG496KPAM is a 5G 4in1 wall and pole mount combo directional antenna designed to deliver robust performance across an exceptionally wide 617-4200MHz frequency range. Offering 4x4 MIMO directional antenna capability, the YEMG496KPAM supports LTE, 5G, IoT and public safety bands, making it ideal for applications that require high-capacity connectivity. The antenna has dimensions of 590mm x 419mm x 143mm and the robust grey UPVC housing ensures durability for indoor and outdoor use.
The YEMG492WPAM is a 5G 4in1 wall and pole mount combo antenna for stadium use cases. Operating in the 1695-2690MHz and 3300-4200MHz frequency bands, the antenna measures 595mm x 419mm x143mm. Optimized for LTE and 5G networks, the YEMG492WPAM has been designed to ensure reliable connectivity and enhanced data throughput for thousands of simultaneous users. This antenna offers the capacity, reliability and performance needed for next generation, high-density wireless deployments.
The YEME491WPAM is a 4G 4in1 pole mount combo single beam lens antenna designed for advanced cellular networks and operates in the 1710-2690MHz frequency range. The antenna covers key bands for 3G, 4G and early 5G deployments, offering excellent sector precision and reduced interference. Measuring 774 × 400 × 400 mm, the antenna is engineered for harsh outdoor environments. It features a rugged UPVC radome and supports mechanical downtilt of up to 20°, making the YEME491WPAM well suited for demanding deployments.
The YEME490WPAM is a 4G 4in1 pole mount combo dual beam lens antenna that operates in the 698-960MHz frequency range and is ideally suited for LTE, NB-IoT and other mid-band applications that require robust and focused signal delivery. The antenna’s standout feature is the generation of two independent beams, each with a ±45° polarization and a beam center at ±33° in the horizontal plane, allowing for sophisticated sectorization and enhanced capacity in dense deployment scenarios. With dimensions of 850mm x 645mm x 850mm and featuring an ASA radome for durability, the YEME490WPAM is ideal for critical outdoor wireless infrastructure.
In addition to the antenna products, Quectel also provides comprehensive antenna design support such as simulation, testing and manufacturing for custom antenna solutions to meet specific application needs. Quectel has regional R&D centers across the globe to ensure it can respond rapidly to customer requirements and ensure smooth antenna integrations.
Attendees to MWC Barcelona can find out more about the complete Quectel end-to-end IoT solutions portfolio, including the antenna range, at stand 5A19.
About Quectel
Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are an end-to-end global IoT solutions provider backed by outstanding support and services.
With a worldwide team of over 5,800 professionals, we lead the way in delivering end-to-end IoT solutions, spanning cellular, GNSS, satellite, Wi-Fi and Bluetooth modules, high-performance antennas, value-added services and full turnkey offerings including ODM services and system integration.
With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.
For more information, please visit www.quectel.com or LinkedIn
View source version on businesswire.com: https://www.businesswire.com/news/home/20260302915004/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer samarbejdsfirmaet TechSparq25.10.2026 06:09:00 CET | Pressemeddelelse
Andersen Consulting udvider sine kompetencer inden for teknologi og forretningstransformation gennem en samarbejdsaftale med TechSparq, en amerikansk virksomhed, der kombinerer strategi, commerce engineering og ai med praktisk implementering. TechSparq er et digitalt konsulenthus, der tilbyder strategi- og rådgivningstjenester, commerce engineering samt tjenester inden for ai og agentbaseret handel til virksomheder inden for detailhandel og forbrugsgoder, luksus og mode samt e-handel og direkte salg til forbrugere. Virksomheden har hovedkontor i Oregon og kombinerer strategisk planlægning med praktisk implementering for at hjælpe kunderne med at udvikle deres digitale initiativer, kundeoplevelse og driftsmodeller. "Vi etablerede vores virksomhed for at bygge bro mellem dem, der udvikler strategien, og dem, der har ansvaret for at føre den ud i livet," udtalte Dedrick Boyd, stifter af og administrerende direktør for TechSparq. "Vores samarbejde med Andersen Consulting giver os mulighed
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom